760 related articles for article (PubMed ID: 11470906)
21. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
22. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
[TBL] [Abstract][Full Text] [Related]
25. Modulation of anxiety through blockade of anandamide hydrolysis.
Kathuria S; Gaetani S; Fegley D; Valiño F; Duranti A; Tontini A; Mor M; Tarzia G; La Rana G; Calignano A; Giustino A; Tattoli M; Palmery M; Cuomo V; Piomelli D
Nat Med; 2003 Jan; 9(1):76-81. PubMed ID: 12461523
[TBL] [Abstract][Full Text] [Related]
26. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
Wiley JL; Martin BR
Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
30. Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages.
Maccarrone M; Attinà M; Bari M; Cartoni A; Ledent C; Finazzi-Agrò A
J Neurochem; 2001 Jul; 78(2):339-48. PubMed ID: 11461969
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
Palmer JA; Higuera ES; Chang L; Chaplan SR
Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
[TBL] [Abstract][Full Text] [Related]
33. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
34. Activation of the endocannabinoid system by organophosphorus nerve agents.
Nomura DK; Blankman JL; Simon GM; Fujioka K; Issa RS; Ward AM; Cravatt BF; Casida JE
Nat Chem Biol; 2008 Jun; 4(6):373-8. PubMed ID: 18438404
[TBL] [Abstract][Full Text] [Related]
35. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
[TBL] [Abstract][Full Text] [Related]
36. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase.
Huitron-Resendiz S; Sanchez-Alavez M; Wills DN; Cravatt BF; Henriksen SJ
Sleep; 2004 Aug; 27(5):857-65. PubMed ID: 15453543
[TBL] [Abstract][Full Text] [Related]
38. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
40. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.
Maccarrone M; Valensise H; Bari M; Lazzarin N; Romanini C; Finazzi-Agrò A
J Immunol; 2001 Jun; 166(12):7183-9. PubMed ID: 11390466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]